RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

CJC-1295 without DAC 10MG + Ipamorelin 10MG 20MG

Categories:

CJC-1295 without DAC and Ipamorelin peptide blend is designed for research-use-only / laboratory-use applications. This 20mg combined peptide kit contains 10mg of CJC-1295 without diacetyl (DAC) and 10mg of Ipamorelin for targeted experimental studies. For research use only.

$100.00

RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

Orders placed Monday-Friday will be shipped the next business day (Excludes Holidays)

Trusted third-party testing ensures each batch’s purity and compliance with regulations.

Product Usage Disclaimer

This product is solely intended for research purposes as a chemical compound. Its designation permits its use exclusively for in vitro testing and laboratory experimentation. All information regarding this product provided on our website is purely educational. By law, any form of bodily introduction of this product into humans or animals is strictly prohibited. It should only be handled by professionals who are licensed and qualified. This product is neither a drug, food, nor cosmetic and must not be misrepresented, misused, or mislabelled as such.

CJC-1295 without DAC (10mg) + Ipamorelin (10mg) 20MG Research-Use-Only Peptide Combo

This product is a combination of two well-studied peptides designed for research applications in laboratories. CJC-1295 without DAC and Ipamorelin are synthetic analogs derived from naturally occurring growth factors, primarily intended for use in scientific investigations involving growth factor signaling pathways. The provided formulation is tailored for researchers working on molecular biology, pharmacology, or related fields.

Research Context

CJC-1295 is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH), while Ipamorelin is a selective peptide agonist for ghrelin receptors. When combined, these peptides are often used in preclinical studies to investigate the regulation of growth hormone secretion, metabolic processes, and potential therapeutic effects in controlled laboratory environments.

Research Overview

CJC-1295 without DAC (Decyl Amide Conjugate) is a modified form of the peptide designed to extend its half-life compared to standard GHRH analogs. This modification allows for prolonged effects on pituitary gland activity, specifically stimulating growth hormone secretion without the need for DAC conjugation, which can alter its pharmacological profile. Ipamorelin, in contrast, is a potent and selective agonist for the A-type ghrelin receptor, primarily influencing growth hormone release in a more targeted manner.

Key Research Focus Areas

  • Hormonal Regulation Studies: Examination of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) dynamics in response to peptide administration, particularly in models of aging, muscle atrophy, or metabolic disorders.
  • Preclinical Toxicity and Pharmacokinetics: Assessment of peptide stability, clearance rates, and potential systemic effects in animal or cell-based systems to inform safety profiles.
  • Neuroendocrine Research: Investigation of peptide-mediated effects on hypothalamic-pituitary axis function, including GH pulsatility and receptor binding affinity studies.
  • Musculoskeletal Development: Studies on muscle growth, bone remodeling, or cartilage regeneration in experimental settings, where peptide effects on tissue-specific growth factors can be isolated.
  • Metabolic and Energy Homeostasis: Evaluation of peptide-induced changes in energy balance, fat metabolism, or appetite regulation in controlled research models.

Important Safety and Compliance Notice

The use of this product is strictly intended for research purposes only. These peptides are not approved for human or animal consumption and have not been evaluated for therapeutic, cosmetic, or diagnostic applications. Research must be conducted in compliance with all applicable regulatory requirements, including local, national, and international laws governing peptide synthesis and biological materials.

Only qualified professionals with appropriate training and oversight should handle these substances. Proper containment, documentation, and disposal procedures must be followed to mitigate risks associated with peptide exposure, including potential toxicity or unintended biological effects.

Product Formulation Details

Component Formulation Expected Application
CJC-1295 without DAC 10mg per vial Prolonged GH secretion via GHRH pathway modulation
Ipamorelin 10mg per vial Selective GH release via ghrelin receptor activation
Total per vial: 20mg combined peptide mixture

This product is provided for research institutions or academic laboratories to support scientific exploration. Consumption or distribution for any purpose other than authorized research is prohibited.

For Research Use Only. Not for Human or Animal Consumption.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 without DAC 10MG + Ipamorelin 10MG 20MG”

Your email address will not be published. Required fields are marked *

RELATED PRODUCTS

Main Logo
ATTENTION: MANDATORY LEGAL DISCLAIMER

*By continuing, you confirm eligibility and legal compliance.